OrbiMed’s Cerus CERS Stock Holding History

OrbiMed’s Portfolio CERS Stock Details CERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-500,000	Closed	-$2.08M	–	134
2014 Q2	$2.08M	Hold	500,000	–	–	0.02%	126
2014 Q1	$2.4M	Buy	+500,000	New	+$3.21M	0.03%	131

Other funds holding CERS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OrbiMed's CERS Position: Q2 2016 in Review

OrbiMed sold out of Cerus (CERS) in Q2 2016, closing a stake of 578,300 shares — an estimated $3.43M sold.

OrbiMed first reported a position in CERS in Q3 2013 and held it in 11 quarters. The position peaked at $43.9M in Q4 2014. 131 funds tracked by Wall St. Rank hold CERS as of Q2 2016.

OrbiMed reported no remaining Cerus position as of Q2 2016 after selling out during the quarter.
OrbiMed sold 578,300 Cerus shares in Q2 2016, an estimated $3.43M.
OrbiMed first reported a position in Cerus in Q3 2013 and held it in 11 quarters.
OrbiMed's Cerus position peaked at $43.9M in Q4 2014.
131 funds tracked by Wall St. Rank held Cerus as of Q2 2016.

Based on OrbiMed's 13F filing for Q2 2016, filed 15 Aug 2016.